Clinical Trial Update: A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose lenalidomide with dexamethasone in relapsed/refractory multiple myeloma patients at high risk for myelosuppression; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED